David Coman

Insider Reports History

Entity: Individual
Location: C/O Lifesci Acquisition II Corp., 250 W 55 Th Street, #3401, New York, NY
Signature: /s/ Christine Pellizzari, Attorney-in-fact for David Coman
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Coman:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Science 37 Holdings, Inc.	Chief Executive Officer, Former Director	Common Stock	0	$0	$5.75	Mar 12, 2024	Direct
Science 37 Holdings, Inc.	Chief Executive Officer, Former Director	Restricted Stock Units	0	$0	$5.75	Mar 12, 2024	Direct
Science 37 Holdings, Inc.	Chief Executive Officer, Former Director	Earn-Out Right	0			Mar 12, 2024	Direct
Science 37 Holdings, Inc.	Chief Executive Officer, Former Director	Stock Option	0			Mar 12, 2024	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by David Coman

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
SNCE	Science 37 Holdings, Inc.	Mar 12, 2024	5	-$487K	4	Mar 12, 2024	Chief Executive Officer, Former Director
SNCE	Science 37 Holdings, Inc.	Aug 12, 2023	3	-$63.6K	4	Aug 15, 2023	Chief Executive Officer
SNCE	Science 37 Holdings, Inc.	Apr 28, 2023	3	$0	4	May 2, 2023	Chief Executive Officer
SNCE	Science 37 Holdings, Inc.	Aug 12, 2022	1	$0	4	Aug 16, 2022	Chief Executive Officer
SNCE	Science 37 Holdings, Inc.	Jan 7, 2022	1	$0	4	Jan 11, 2022	Chief Executive Officer
SNCE	Science 37 Holdings, Inc.	Oct 6, 2021	2	$0	4/A	Oct 12, 2021	Chief Executive Officer, Director
SNCE	Science 37 Holdings, Inc.	Oct 6, 2021	0	$0	3	Oct 8, 2021	Chief Executive Officer, Director